1,2-distearoylphosphatidylethanolamine has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, H; Bi, D; Guo, Y; Han, M; Li, H; Li, Y; Wang, X | 1 |
| Chen, Z; Li, C; Li, L; Liu, B; Wang, F | 1 |
2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Cancer of Cervix
| Article | Year |
|---|---|
Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice.
Topics: Acetogenins; Animals; Antineoplastic Agents, Phytogenic; Cell Proliferation; Dose-Response Relationship, Drug; Drug Compounding; Drug Liberation; Excipients; Female; Folic Acid; Folic Acid Transporters; HeLa Cells; Humans; Lecithins; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Nanoparticles; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Solubility; Technology, Pharmaceutical; Time Factors; Tumor Burden; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; HeLa Cells; Humans; Hyaluronic Acid; Lipids; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Particle Size; Phosphatidylethanolamines; Poloxamer; Tissue Distribution; Uterine Cervical Neoplasms | 2017 |